M&A Deal Summary |
|
---|---|
Date | 2022-11-29 |
Target | Apollo Endosurgery |
Sector | Life Science |
Buyer(s) | Boston Scientific |
Deal Type | Add-on Acquisition |
Deal Value | 615M USD |
Advisor(s) | Piper Sandler & Co. (Financial) Cooley (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1979 |
Sector | Medical Products |
Employees | 48,000 |
Revenue | 14.2B USD (2023) |
Boston Scientific is a medical technology company. Boston Scientific's products and technologies are used to diagnose or treat a wide range of medical conditions, including heart, digestive, pulmonary, vascular, urological, women's health, and chronic pain conditions. Boston Scientific was founded in 1979 and is based in Marlborough, Massachusetts.
DEAL STATS | # |
---|---|
Overall | 60 of 64 |
Sector (Life Science) | 6 of 6 |
Type (Add-on Acquisition) | 47 of 50 |
State (Texas) | 1 of 1 |
Country (United States) | 46 of 49 |
Year (2022) | 3 of 4 |
Size (of disclosed) | 10 of 34 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2022-08-15 |
Obsidio
Columbia, South Carolina, United States Obsidio is a privately-held company that has developed the Gel Embolic Material technology used for embolization of blood vessels in the peripheral vasculature. Obsidio is based in Columbia, South Carolina. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2022-12-11 |
Acotec
Beijing, China Acotec is a medical technology company that offers solutions designed for a variety of interventional procedures in innovative medical solutions, including drug-coated balloons (DCBs), which are used in the treatment of vascular and other diseases. In 2016, the company launched the first peripheral DCB in China after receiving approval from the National Medical Products Administration. The Acotec portfolio also includes radiofrequency ablation technologies and thrombus aspiration catheters, as well as more than 20 other products in various stages of development across a range of specialties. Acotec was incorporated in 2020 and is headquartered in Beijing, China. |
Buy | - |